EquityZen Growth Technology Fund LLC - Series 317
Raised
$5M
Investors
95
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 317 is a Delaware pooled investment fund filed by EquityZen Advisors LLC on 2018-10-03, reporting $5.0M raised from 95 investors with a $10K minimum investment. The offering claimed exemptions under Rule 506(b) and Section 3(c)(1), consistent with EquityZen's platform model for pre-IPO secondary market access.
This pre-IPO pooled fund uses the standard 506(b)/3(c)(1) exemption pattern typical of retail-accessible alternative investment platforms. The $10K minimum investment represents the lower end of the accessibility spectrum for pre-IPO vehicles, enabling broader investor participation compared to institutional-only offerings.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
